Research Reference · Skin & Tissue Repair Blend
GLOW (Three-Peptide Blend)
A three-peptide research blend — GHK-Cu, BPC-157 and TB-500 — combining collagen, repair-signaling and cell-migration research in one vial.
At a glance
GLOW is a three-peptide research blend: GHK-Cu (50 mg) with BPC-157 and TB-500 at 10 mg each — 70 mg in total. It adds the most-studied copper peptide to the BPC-157 + TB-500 “Wolverine” pairing. No study of the blend itself has been published; the evidence belongs to the components and is mostly lab and animal work.
What it’s studied for
GLOW
GLOW (70mg) · $104.99
Third-party tested · batch-matched COA · research use only
How it works
GLOW combines three peptides with separate, well-documented mechanisms. GHK-Cu — the largest share of the vial — stimulated collagen synthesis in fibroblast cultures and is linked in gene-data analyses to repair and skin regeneration. 2,1,7
BPC-157 is studied for repair signaling across skin wounds and tendon models, 3,4 and TB-500 (thymosin beta-4) controls actin, the protein cells use to move, and sped wound closure in rats. 5,6
The blend lets a lab look at matrix, repair and migration pathways in one model. No study of the combined blend has been published, so each component’s evidence should be read on its own terms.
Related research
Frequently asked questions
What is in GLOW?
How is GLOW different from KLOW?
How is GLOW different from BB?
Has the GLOW blend itself been studied?
How is each batch verified?
Identifiers
| Components | GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) |
|---|---|
| Total peptide | 70 mg per vial |
| GHK-Cu | C14H23CuN6O4 · CAS 89030-95-5 · PubChem CID 71587328 |
| BPC-157 | C62H98N16O22 · CAS 137525-51-0 · PubChem CID 9941957 |
| TB-500 | Thymosin beta-4 / its 17–23 fragment — see the TB-500 page |
| Supplied as | Lyophilized (freeze-dried) powder |
Component identifiers checked against PubChem.
Research timeline
- 1988GHK-Cu stimulates collagen synthesis in fibroblasts. 2
- 1999Thymosin beta-4 speeds wound closure in rats. 6
- 2011BPC-157 increases tendon-cell outgrowth, survival and migration. 4
- 2015Review of GHK in skin regeneration. 7
- 2018Review links GHK-Cu’s actions to gene data. 1
- 2021Reviews of BPC-157 in wound healing 3 and of thymosin beta-4. 5
Key studies
| Study | Model | What it found |
|---|---|---|
| Maquart 1988 2 | Cell (GHK-Cu) | Collagen synthesis stimulated at nanomolar concentrations. |
| Malinda 1999 6 | Rat + cell (Tβ4) | Faster wound closure; more skin-cell migration. |
| Chang 2011 4 | Cell (BPC-157) | More tendon-cell outgrowth, survival and migration. |
| Pickart 2015 7 | Review (GHK) | Roles in skin regeneration; broad gene-expression effects. |
Sources
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Pickart L, Margolina A. Int J Mol Sci, 2018. Free full textReview
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Maquart FX, et al. FEBS Lett, 1988.
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Seiwerth S, et al. Front Pharmacol, 2021. Free full textReview
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Chang CH, et al. J Appl Physiol, 2011.
- Progress on the Function and Application of Thymosin β4. Xing Y, et al. Front Endocrinol (Lausanne), 2021. Free full textReview
- Thymosin beta4 accelerates wound healing. Malinda KM, et al. J Invest Dermatol, 1999.
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Pickart L, et al. Biomed Res Int, 2015. Free full textReview
Last reviewed September 2026 by Midwest Compounds. Every source above was checked against its original publication.